Literature DB >> 21892707

The effects of PVP(Fe(III)) catalyst on polymer molecular weight and gene delivery via biodegradable cross-linked polyethylenimine.

Victor W T Shum1, Nathan P Gabrielson, M Laird Forrest, Daniel W Pack.   

Abstract

PURPOSE: Crosslinked, degradable derivatives of low-molecular-weight polyethylenimine (PEI) are relatively efficient and non-cytotoxic gene delivery agents. To further investigate these promising materials, a new synthetic approach was developed using a poly(4-vinylpyridine)-supported Fe(III) catalyst (PVP(Fe(III))) that provides more facile synthesis and enhanced control of polymer molecular weight.
METHODS: Biodegradable polymers (D.PEI) comprising 800-Da PEI crosslinked with 1,6-hexanediol diacrylate and exhibiting molecular weights of 1.2, 6.2, and 48 kDa were synthesized utilizing the PVP(Fe(III)) catalyst. D.PEI/DNA polyplexes were characterized using gel retardation, ethidium bromide exclusion, heparan sulfate displacement, and dynamic light scattering. In vitro transfection, cellular uptake, and cytotoxicity of the polyplexes were tested in human cervical cancer cells (HeLa) and human breast cancer cells (MDA-MB-231).
RESULTS: D.PEIs tightly complexed plasmid DNA and formed 320- to 440-nm diameter polyplexes, similar to those comprising non-degradable, 25-kDa, branched PEI. D.PEI polyplexes mediated 2- to 5-fold increased gene delivery efficacy compared to 25-kDa PEI and exhibited 20% lower cytotoxicity in HeLa and no toxicity in MDA-MB-231. In addition, 2- to 7-fold improved cellular uptake of DNA was achieved with D.PEI polyplexes.
CONCLUSIONS: PVP(Fe(III)) catalyst provided a more controlled synthesis of D.PEIs, and these materials demonstrated improved in vitro transfection efficacy and reduced cytotoxicity .

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892707      PMCID: PMC3465843          DOI: 10.1007/s11095-011-0576-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers.

Authors:  D L McKenzie; E Smiley; K Y Kwok; K G Rice
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

2.  Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library.

Authors:  D M Lynn; D G Anderson; D Putnam; R Langer
Journal:  J Am Chem Soc       Date:  2001-08-22       Impact factor: 15.419

Review 3.  Cellular endocytosis and gene delivery.

Authors:  Jennifer E Ziello; Yan Huang; Ion S Jovin
Journal:  Mol Med       Date:  2010-02-03       Impact factor: 6.354

4.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine.

Authors:  M A Gosselin; W Guo; R J Lee
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

Review 5.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

6.  Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer.

Authors:  M L Drumm; H A Pope; W H Cliff; J M Rommens; S A Marvin; L C Tsui; F S Collins; R A Frizzell; J M Wilson
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Characterization of commercially available and synthesized polyethylenimines for gene delivery.

Authors:  A von Harpe; H Petersen; Y Li; T Kissel
Journal:  J Control Release       Date:  2000-11-03       Impact factor: 9.776

8.  A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery.

Authors:  M Laird Forrest; James T Koerber; Daniel W Pack
Journal:  Bioconjug Chem       Date:  2003 Sep-Oct       Impact factor: 4.774

9.  Monitoring the effect of PEGylation on polyethylenimine in vivo using nuclear imaging technique.

Authors:  Eun-Mi Kim; Hwan-Jeong Jeong; In-Kyu Park; Chong Soo Cho; Hee-Seung Bom; Chang-Guhn Kim
Journal:  Nucl Med Biol       Date:  2004-08       Impact factor: 2.408

10.  In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.

Authors:  M A Kay; S Rothenberg; C N Landen; D A Bellinger; F Leland; C Toman; M Finegold; A R Thompson; M S Read; K M Brinkhous
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.